kidney cancer

Open Access
Impact of Polypharmacy on Perioperative Outcomes of Robot-assisted Laparoscopic Partial Nephrectomy for Small Renal Masses
YUKI NEMOTO, HIROKI ISHIHARA, KAZUTAKA NAKAMURA, KOICHI NISHIMURA, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, TSUNENORI KONDO and TOSHIO TAKAGI

In Vivo September 2025, 39 (5) 2801-2809; DOI: https://doi.org/10.21873/invivo.14079
You have access
Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma
MAKI YOSHINO, HIROKI ISHIHARA, YUDAI ISHIYAMA, HIDEKAZU TACHIBANA, DAISUKE TOKI, KAORI YAMASHITA, HIROHITO KOBAYASHI, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, TOSHIO TAKAGI, JUNPEI IIZUKA, HIDEKI ISHIDA, TSUNENORI KONDO and KAZUNARI TANABE

In Vivo September 2021, 35 (5) 2855-2862; DOI: https://doi.org/10.21873/invivo.12573
You have access
Efficacy of Cabozantinib in Metastatic Papillary Renal Cell Carcinoma Following Ineffective Treatment With Initial Therapy of Nivolumab and Ipilimumab
HIDEKAZU TACHIBANA, YUDAI ISHIYAMA, MAKI YOSHINO, KAORI YAMASHITA, DAISUKE TOKI and TSUNENORI KONDO

In Vivo May 2021, 35 (3) 1743-1747; DOI: https://doi.org/10.21873/invivo.12433
You have access
Estimating the Lifespan of Elderly Patients With Cerebral Metastases from Kidney Cancer
DIRK RADES, TRANG NGUYEN and STEVEN E. SCHILD

In Vivo May 2020, 34 (3) 1321-1324; DOI: https://doi.org/10.21873/invivo.11908
You have access
Interval Between Cancer Diagnosis and Radiotherapy – An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer
DIRK RADES, RAPHA HAUS, STEFAN JANSSEN and STEVEN E. SCHILD

In Vivo March 2020, 34 (2) 767-770; DOI: https://doi.org/10.21873/invivo.11836

Main menu

User menu

Search

kidney cancer